Statistics for Immunome (id:5733 IMNM)

Valuation metrics

Market cap

618.24M

Enterprise value

378.11M

Trailing P/E (ttm)

-1.83

Forward P/E

-3.42

PEG ratio

-3.42

Price/Sales (ttm)

61.04

Price/Book (mrq)

1.99

Enterprise Value/Revenue

37.33

Enterprise Value/EBITDA

-3.42

Overview

Shares outstanding

62.29M

Float

44.83M

Shares short

10.47M

% Held by insiders

0.17%

% Held by institutions

0.83%

Average volume (10 days)

890.76K

Average volume (90 days)

Price summary

52-Week low

6.93

52-Week high

30.96

52-Week change

18.53%

Beta

1.82

50-Day moving average

13.12

200-Day moving average

16.20

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,505.70%

Operational effectiveness

Return on assets

-39.89%

Return on equity

-276.36%

Income statement

Revenue (ttm)

0.19

Revenue per share (ttm)

0.19

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

52.80M

Net income to common (ttm)

-305,348,000.00

Diluted EPS (ttm)

-7.54

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

240.13M

Total cash per share (mrq)

3.85

Total debt (mrq)

2.77M

Total Debt/Equity (mrq)

0.01

Current ratio (mrq)

617.40%

Book value per share (mrq)

4.97

Cash flow

Cash flow statement

-86,193,000.00

Levered free cash flow (LFCF)

-104,477,128.00